been used as a dietary supplement. 9 In addition, therapeutic effects of NAM have been reported in a range of diseases from pellagra, sepsis, to type I diabetes and fatty liver. 10, 11 Mechanistically, NAM may modulate fatty acid metabolism, inflammation, oxidative stress, cell proliferation and apoptosis. In kidneys, Tran et al showed that supplementation of NAM may reverse established ischaemic acute kidney injury (AKI). 13 Remarkably, Poyan et al further demonstrated the therapeutic potential in human AKI patients. 14 However, the effect of NAM in chronic kidney disease and related renal interstitial fibrosis, has not been reported. In this study, we conducted in vivo and in vitro experiments to examine the effects of NAM on the development of chronic renal pathologies, including renal interstitial fibrosis.
| MATERIAL S AND ME THODS

| Antibodies and reagents
Following primary antibodies were used in this study: anti-α-SMA from Servicebio. Secondary antibodies were purchased from Thermo-Fisher Scientific. NAM (72340) was purchased by SigmaAldrich, and recombinant human TGF-β1 (GF111) was from EMD Millipore.
| Mouse model of unilateral urethral obstruction
Male C57BL/6 mice (8 weeks to 10 weeks) were purchased from Hunan Slack King Experimental Animal Company (Changsha, China). Unilateral ureteral obstruction surgery was performed by the procedure described before. 15, 16 Briefly, mice were anaesthetized with pentobarbital (60 mg/kg) and mouse body temperature was maintained at approximately 36.5°C by a rectal probe of the Homeothermic Blanket Control Unit (507220F, Harvard Apparatus).
A small incision was made on the left side of the mouse to expose and separate the ureter. In the middle of left ureter, 2 points were sutured with 4-0 silk thread. The control mice only exposed the left ureter to separate without ligation. For NAM treatment, mice were intraperitoneally injected with different doses of NAM (200 mg/kg, 400 mg/kg, 800 mg/kg) one hour before unilateral urethral obstruction (UUO) surgery, and then injected daily at the same point in time until the day before being sacrificed. The mice were sacrificed at 14 days after UUO surgery and their left kidneys were harvested for biochemical and morphological examinations.
| Cells and TGF-β treatment
The Boston University mouse proximal tubular cell line (BUMPT) 
| Histological analysis of kidney tissues
Kidney tissue was fixed in 4% paraformaldehyde solution, embedded in paraffin and sectioned at 4µm. Haemotoxylin and eosin (H&E) staining and Masson trichrome staining were performed according to the standard protocols provided by the manufacturer (Servicebio). The atrophic renal tubules were characterized by thinning of tubular cell body, dilation of the tubule, necrotic debris in the lumen, and significant expansion of the interstitial space. Tubular atrophy score was calculated by using a scoring system based on the percentage of atrophic tubules (0; 1, <25%; 2, 25% to 50%; 3, 50%-75%; 4, >75%). The type I, type III and type IV collagen fibrils were stained aniline blue by Masson staining. To quantify the fibrotic area, 10 to 20 stained areas (magnification 100×) were randomly selected. ImageProPlus software was then used to assess the ratio of positively (blue) stained area to the entire area (excluding glomerular, small vena cava and blood vessels), which was expressed as the percentage of fibrotic area.
| Immunohistochemical analysis of T cells and macrophages
Paraffin-embedded tissue sections were deparaffinized, rehydrated and placed in 0.1 mol/L sodium citrate (pH 6.0). Then the paraffin sections were heated in an oven for antigen retrieval. These sections were incubated in 3% hydrogen peroxide and blocked in 2% normal goat serum. The sections were then exposed to 1:250 anti-CD3 or 1:1000 anti-F4/80 antibodies overnight at 4°C, followed by rewarming at room temperature and exposure to biotinylated 
| Western blot analysis
Cells and kidney tissues were lysed in a lysis buffer containing 2% SDS The ratio of FN/GAPDH or α-SMA/GAPDH of sham control was arbitrarily set as 1, and the ratios of other groups were normalized with control to determine fold changes. These data were expressed as mean ± SD (n = 3). *P < 0.05, ***P < 0.001, significantly different from the sham group (with 0 NAM), # P < 0.05, ## P < 0.01, significantly different from UUO (with 0 NAM)
were incubated with blocking buffer containing 5% bovine serum albumin and then exposed to specific primary antibodies overnight at 4°C. Finally, the membranes were incubated with secondary antibodies to reveal signal with the ECL kit (EMD Millipore, WBKLS0500).
| Real-time RT-PCR
For quantitative analysis of gene expression, total RNA was isolated using the Trizol kit (12183555, Invitrogen,). RNA concentration was measured by NanoDrop2000 and cDNA was synthesized by using the Takara kit (RR047A, Takara). RT-PCR was performed according to the standard procedure of the Takara kit (RR820A, Takara). All data were analysed by the LightCycler ® 96 SW 1.1 software, the threshold period (Ct) was determined and the mRNA expression of the specific gene in the target sample was calculated by Ct values. Primer sequences for the specific genes used in this study are listed in Table 1 .
| Statistics
Qualitative data including Western blots and various morphological images were representatives of at least three experiments.
Quantitative data were expressed as means ± SD (standard deviation) and statistical analysis were performed using GraphPad Prism software. The 2-tailed unpaired or paired Student's t tests were used to determine the statistical difference between two groups. ANOVA followed by Tukey's post hoc tests were used to determine statistical differences between multiple groups. The value of P < 0.05 was considered significantly different.
| RE SULTS
| NAM reduces UUO-induced renal interstitial fibrosis
We examined the effect of NAM on renal fibrosis during UUO.
Different doses of NAM were given to mice with UUO. After 14 days, the mice were sacrificed and the obstructed kidney was taken for morphological and biochemical analysis. We first used
Masson trichrome staining to detect collagen deposition in tissues of the obstructed kidneys. As shown in Figure 1A , sham control kidneys had minimal staining regardless of NAM. UUO induced significant increases in positive Masson staining (blue), which were notably reduced by 200-800 mg/kg NAM. We further quantified the fibrosis staining by morphometric analyses using ImageProPlus. After two weeks of UUO, there was about 15% of renal tissue area stained positive, which was reduced to about 7% by NAM ( Figure 1B ).
F I G U R E 2 Nicotinamide (NAM) reduces unilateral urethral obstruction (UUO)-induced tubular atrophy. C57BL/6 mice were subjected to UUO surgery or sham operation. Different doses of NAM or saline were intraperitoneally injected an hour before the surgery and daily thereafter. The mice were sacrificed at 14 days after surgery to collect obstructed kidneys for haematoxylin and eosin histological staining.
(A) Representative images of haematoxylin and eosin staining. Scale bar: 200 µmol/L. (B) Tubular atrophy score of haematoxylin and eosin staining. Tubular atrophy was graded by 0, 1 (1%-25%), 2 (26%-50%), 3 (51%-75%), 4 (76%-100% tubules showing atrophy). These data were expressed as mean ± SD (n = 6). ***P < 0.001, significantly different from the sham group (with 0 NAM), # P < 0.05, ## P < 0.01, significantly different from the UUO group (with 0 NAM) Furthermore, we examined the expression of fibrosis protein markers, including fibronectin (FN) and α-smooth muscle actin (α-SMA).
The immunoblot results showed that both FN and α-SMA accumulated dramatically in the obstructed kidney tissues, and this accumulation was significantly suppressed by the administration of NAM ( Figure 1C ). Semi-quantification by densitometry further verified this conclusion ( Figure 1D) . Interestingly, the effect of NAM on renal fibrosis did not show a good dose-dependence, suggesting the possibility of reaching the maximal effect at 200 mg/kg. These results suggest that NAM has inhibitory effects on renal interstitial fibrosis. 
| UUO-induced tubule atrophy is alleviated by NAM
| NAM suppresses UUO-induced tubular cell apoptosis
Tubular apoptosis contributes significantly to the progressive cell loss and renal degeneration in renal interstitial fibrosis. It is also closely related to tubular atrophy and particularly its progression to tubular atresia. 2, 3, 23 To determine the effect of NAM on tubular apoptosis in UUO, we first performed TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling) staining in kidney tissues. As shown in Figure 3A ,B, while almost no TUNELpositive cells were detected in sham-operated mice, about 20 apoptotic cells/mm 2 kidney tissue were detected after 14 days of UUO.
Importantly, administration of 400 mg/kg NAM reduced the number of apoptotic cells to 9. We further examined caspase activation by immunoblot analysis of active or cleaved caspase 3 (C-CAS3). As shown in Figure 3C , UUO induced an obvious increase in cleaved Figure 3D ). Together, these results indicate that NAM reduces apoptosis in UUO.
| UUO-induced renal inflammation is alleviated by NAM
Inflammation is another important factor for the initiation and progression of renal interstitial fibrosis diseases. 2, 3, 5, 24 In this aspect, infiltration and phenotypic change of macrophages play a critical role. 25, 26 To examine the role of NAM in UUO-associated inflammation, we examined the infiltration of T cells and macrophages in kidney tissues. We further analysed the expression of pro-inflammatory cytokines, including tumour necrosis factor alpha (TNF-α) and interleukin-1β (IL-1β). As shown in Figure 4A , T cells (CD3 stain- 
| NAM attenuates TGF-β-induced pro-fibrotic changes in cultured proximal tubular cells
TGF-β is a key factor in renal interstitial fibrosis that may affect multiple cell types including renal proximal tubules. Figure 5A ). In Western blot, we detected the expression of fibronectin (FN, a fibrotic matrix protein) and Vimentin (a cell dedifferentiation marker) in TGF-β-treated cells, whereas E-cadherin was decreased ( Figure 5B,C) . Importantly, the changes of these proteins during TGF-β treatment were largely attenuated by NAM 
F I G U R E 4 Unilateral urethral obstruction (UUO)-induced kidney inflammation is alleviated by nicotinamide (NAM)
.
| NAM inhibits TGF-β-induced apoptosis in proximal tubular cells
We showed the inhibitory effect of NAM on renal tubular apoptosis during UUO in mice (Figure 3 
| Inflammatory response of BUMPT cells induced by TGF-β is inhibited by NAM
The inflammatory response of renal tubular epithelial cells is a key point to the development of renal interstitial fibrosis. 
| D ISCUSS I ON
Renal interstitial fibrosis is a pathological hallmark of progressive kidney diseases in almost all etiologies. At present, there is an urgent The ratio of FN/GAPDH, vimentin/GAPDH or E-cadherin/GAPDH of sham control was arbitrarily set as 1, and the ratios of other groups were normalized with the control to determine fold changes. These data were expressed as mean ± SD (n = 3). *P < 0.05, **P < 0.01, significantly different from the control group with 0 NAM, # P < 0.05, significantly different from the TGF-β group with 0 NAM need to identify effective treatments for renal fibrosis, which is generally considered to be irreversible. NAM is a member of the vitamin B family that was recently shown to have a therapeutic potential for AKI. 13, 14 However, it is unknown whether NAM and other NAD + -related compounds may have beneficial effects on chronic kidney pathologies, especially renal fibrosis. In this study, Chronic or persistent inflammation is another important factor driving the progression of renal fibrosis. 2, 3, 5, 24, 25 In our study, NAM showed significant anti-inflammation effects. We specifically examined macrophage and T cell infiltration in renal tissues during UUO, which was significantly suppressed by NAM. In addition, NAM reduced the expression of pro-inflammatory cytokines, such as TNF-α and IL-1β ( Figure 3) . Interestingly, cultured tubular cells produced pro-inflammatory cytokines in response to TGF-β1 treatment, and this production was also suppressed by NAM (Figure 7 ). These results, together, suggest that NAM may antagonize renal interstitial fibrosis by attenuating inflammation. (GAPDH) 35 and inhibition of PARP-1 can protect against ischaemic kidney injury by preserving tubular cell ATP. 36 NAM has been reported to have protective effects in a rat model of Alzheimer's disease by inhibiting PARP-1. 37 Sirtuins are a family of NAD-dependent deacetylases that play regulatory functions in a variety of tissues and organs, including kidneys. 38 Of much relevance to our current study, NAM was recently shown to reduce ageing-associated susceptibility to AKI in a Sirt1-dependent manner. 39 Future studies should investigate the effects of NAM on cellular bioenergentics, PARP-1 and sirtuins in experimental models of renal fibrosis to gain better understanding of its anti-fibrotic effect.
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